Just in case you folks want to remind Nick, CFO Dupont, that there are still folks out there waiting for a fair resolution to their deadly weed killer.
"For the full year, DuPont earned almost $2.8 billion, or $2.95 per share, on revenue of $34.8 billion. That's down from last year's net income of almost $3.5 billion, or $3.68 per share, on revenue of $33.7 billion. Sales volumes fell 2 percent.
DuPont said it expects operating earnings excluding significant items will range from $3.85 to $4.05 per share in 2013, up from $3.77 per share last year.
One-time items affecting fourth-quarter results included $135 million to resolve legal claims stemming from the use of DuPont's Imprelis weedkiller, bringing the total amount spent on Imprelis claims to $750 million.
DuPont chief financial officer Nick Fanandakis said the company was working to validate and resolve claims regarding damage to trees, particularly evergreens such as Norway spruce and white pine, linked to the weed killer.
"We want to bring closure to this as soon as possible," he said."